Inner Mongolia Furui Medical Science Co., Ltd.
300049.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$10.69B
Close$
$50.55
25.2% upside
Current Fair Value
25.2% upsideUndervalued by 25.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $10.69 Billion |
|---|---|
| Enterprise Value | $10.20 Billion |
| Dividend Yield | $0.15 (0.37%) |
| Earnings per Share | $0.59 |
| Beta | -0.41 |
| Outstanding Shares | 263,053,099 |
Return
| Return on Equity | 8.45% |
|---|---|
| Return on Assets | 4.79% |
| Return on Invested Capital | 13.26% |
Valuation & Multiples
| P/E Ratio | 64.27 |
|---|---|
| PEG | 169.21 |
| Price to Sales | 6.73 |
| Price to Book Ratio | 4.49 |
| Enterprise Value to Revenue | 6.23 |
| Enterprise Value to EBIT | 25.67 |
| Enterprise Value to Net Income | 61 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 24, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$394.65 M
Average shareholder expectationNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$409.05 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Inner Mongolia Furui Medical Science Co., Ltd.
946 employees
CEO: Guanyi Wang Inner Mongolia Furui Medical Science Co., Ltd. functions as a dedicated platform offering specialized healthcare services. The company's primary focus lies in the liver disease sector, where it delivers a full spectrum of solutions encom...